The Thalassaemia International Federation was established in 1986 by patients and parents
to promote and establish equal access to quality services for the thalassaemia community
across the world. To fulfil this goal one of the main strategies of the organisation has been the
development of standards and guidelines for the clinical management of patients with thalassaemia.
In this effort, TIF has been recruiting leading health and medical experts from the
field of clinical research and management, so that the advice reaching the practicing clinician
is authoritative and evidence based. TIF published its first Guidelines for the Clinical Management
of Thalassaemia back in 2000, the first comprehensive Guidelines ever to be published,
and followed on in updated and extensive versions in 2007 and 2008.